Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 3 II, 1999, Pages 421-426

  Spahn, Joseph D ^a,b   Leung, Donald Y M ^a,b   Chan, Mark T S ^a,b   Szefler, Stanley J ^a,b,c   Gelfand, Erwin W ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b Children's Hospital Colorado   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Glucocorticoid insensitive asthma; Glucocorticoids; Inflammation; Intravenous immunoglobulin; Steroid resistant asthma

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; IMMUNOGLOBULIN; PREDNISONE; TRITIUM;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BINDING AFFINITY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LIGAND BINDING; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; STEROID THERAPY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; DEXAMETHASONE; DRUG EVALUATION; DRUG RESISTANCE; DRUG SYNERGISM; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LYMPHOCYTE ACTIVATION; MALE; PREDNISONE; RECEPTORS, GLUCOCORTICOID; SPIROMETRY; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 0033051612     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70466-5     Document Type: Article

References (26)

1. Spahn JD, Leung DYM, Szefler SJ. Difficult to control asthma evaluation and management. In: Szefler SJ, Leung DYM, editors. Severe asthma: pathogenesis and clinical management. New York: Marcel Dekker Inc; 1995. p. 497-535.
2. Mazer BD, Gelfand EW. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 1991;87:976-83.
3. Jakobsson T, Croner S, Kjellman N-IM, Pettersson A, Vassella C, Bjorksten B. Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma. Allergy 1994;49:413-20.
4. Gelfand EW, Landwehr LP, Mazer B. Intravenous immune globulin: an alternative therapy in steroid dependent allergic diseases. Clin Exp Immunol 1996;10461-6.
5. Amran D, Renz H, Lack G, Bradley K, Gelfand EW. Suppression of cytokine-dependent human T-cell proliferation by intravenous gammaglobulin. Clin Immunol Immunopathol 1994;73:180-6.
6. Leung DYM, Burns J, Newburger J, Geha RS. Reversal of immunoregulatory abnormalities in Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest 1987;79:468-72.
7. Carmichael J, Paterson IC, Diaz P, Crompton GK, Kay AB, Grant IWB. Corticosteroid resistance in chronic asthma. BMJ 1981;282:1419-22.
8. Chan MTS, Leung DYM, Szefler SJ, Spahn JD. Difficult-to-control asthma: clinical characteristics of steroid insensitive asthma. J Allergy Clin Immunol 1998;101:594-601.
9. Lee T, Brattsand R, Leung DYM. Corticosteroid action and resistance in asthma. Am J Respir Crit Care Med 1996;154:81-79.
10. Spahn JD, Leung DYM, Szefler SJ. New insights into the pathogenesis and management of steroid-resistant asthma. J Asthma 1997;34:177-94.
11. Sher ER, Leung DYM, Surs W, Kam JC, Zeig G, Kamada AK, et al. Steroid-resistant asthma: cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994;39:33-9.
12. Kam JC, Szefler SJ, Surs W, Sher ER, Leung DYM. Combination of IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993;151:3460-6.
13. Adcock I, Lane S, Brown C, Peters M, Lee T, Barnes P. Differences in binding of glucocorticoid receptors to DNA in steroid resistant asthma. J Immunol 1995;154:3500-5.
14. Leung DYM, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J Exp Med 1997;186:1567-74.
15. Leung DYM, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, et al. Dys-regulation of interleukin-4, interleukin-5, and interferon-γ gene expression in steroid-resistant asthma. J Exp Med 1995;181:33-40.
16. Crabtree GR, Smith KA, Munck A. Glucocorticoid receptors. In: Catovsky D, editor. Methods in hematology. Vol 2. The leukemic cell. New York: Churchill Livingstone; 1981. p. 252-70.
17. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
18. Szefler SJ. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol 1991;88:147-65.
19. Sertl K, Clark T, Kaliner M. Corticosteroids: their biologic mechanisms and application to the treatment of asthma. Am Rev Respir Dis 1990;141:s1-96.
20. Schwartz HJ, Lowell FC, Melby JC. Steroid resistance in bronchial asthma. Ann Intern Med 1968;69:493-9.
21. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai JJ, Frew AJ, et al. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991;144:1016-25.
22. Alvarez J, Surs W, Leung DYM, Iklé D, Gelfand EW, Szefler SJ. Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol 1992;89:714-21.
23. Spahn JD, Szefler SJ, Surs W, Nimmagadda SR, Doherty DE, Leung DYM. A novel action of interleukin-13: induction of diminished monocyte glucocorticoid receptor binding affinity. J Immunol 1996;157:2654-9.
24. Vrugt B, Wilson S, Van Flaxen E, Born A, Shut JK, Holgate ST, et al. Effects of high dose immunoglobulin in two severe corticosteroid insensitive asthmatic patients. Thorax 1997;52:662-4.
25. Spahn JD, Leung DYM, Surs W, Harbeck RJ, Nimmagadda S, Szefler SJ. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation. Am J Respir Crit Care Med 1995;151:1709-14.
26. Salmun LM, Barlan I, Wolf H, Eibl M, Twarog F, Geha RS, et al. Intravenous immunoglobulin for the treatment of severe asthma [abstract]. J Allergy Clin Immunol 1997;99:S268.